Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
< b > Condition < /b > : Diabetes Mellitus, Type 2 < br/ > < b > Interventions < /b > : Drug: INSULIN GLARGINE; Drug: metformin; Drug: repaglinide; Drug: acarbose; Drug: sitagliptin < br/ > < b > Sponsor < /b > : Sanofi < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2016 Category: Research Source Type: clinical trials